SLC6A3 and schizophrenia: DAT gene expression levels in the peripheral blood and nervous system have been investigated in many neuropsychiatric disorders such as schizophrenia, Parkinson’s disease, attention deficit hyperactivity disorder, alcohol, cannabis, and nicotine addiction [11].